NASH - NONALCOHOLIC STEATOHEPATITIS

Clinical trials for NASH - NONALCOHOLIC STEATOHEPATITIS explained in plain language.

Never miss a new study

Get alerted when new NASH - NONALCOHOLIC STEATOHEPATITIS trials appear

Sign up with your email to follow new studies for NASH - NONALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 6 Completed 4 Terminated 1

Drug trial aims to stop deadly bleeding in scarred livers

Prevention Terminated

This study tested whether a drug called belapectin could prevent the development of esophageal varices—dangerous, swollen veins in the esophagus—in people with advanced liver scarring (cirrhosis) caused by NASH. It involved 357 adults who had cirrhosis but did not yet have these …

Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS

Phase: PHASE2, PHASE3 • Sponsor: Galectin Therapeutics Inc. • Aim: Prevention

Last updated Mar 20, 2026 14:48 UTC

NASH - NONALCOHOLIC STEATOHEPATITIS

Get alerted when new NASH - NONALCOHOLIC STEATOHEPATITIS trials appear

Drug trial aims to stop deadly bleeding in scarred livers